Tue, May 29, 2012
Mon, May 28, 2012
Sun, May 27, 2012
Sat, May 26, 2012
Fri, May 25, 2012
[ Fri, May 25th 2012 ] - Market Wire
GenVec Reports Inducement Award
Thu, May 24, 2012
Wed, May 23, 2012
[ Wed, May 23rd 2012 ] - Market Wire
Moody's Upgrades Mylan
Tue, May 22, 2012
Mon, May 21, 2012
Sun, May 20, 2012
Sat, May 19, 2012
Fri, May 18, 2012
Thu, May 17, 2012
Wed, May 16, 2012
Tue, May 15, 2012
[ Tue, May 15th 2012 ] - Market Wire
CryoLife to Acquire Hemosphere
Mon, May 14, 2012

B. Riley Revises Timing of STAAR Surgical Presentation at Investor Conference


//health-fitness.news-articles.net/content/2012/ .. urgical-presentation-at-investor-conference.html
Published in Health and Fitness on Monday, May 21st 2012 at 13:26 GMT by Market Wire   Print publication without navigation


B. Riley Revises Timing of STAAR Surgical Presentation at Investor Conference -- MONROVIA, Calif., May 21, 2012 /PRNewswire/ --

B. Riley Revises Timing of STAAR Surgical Presentation at Investor Conference

[ ]

MONROVIA, Calif., May 21, 2012 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: [ STAA ]), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that its presentation time at the 13th Annual B. Riley & Co. Investor Conference has been revised and will be on Wednesday, May 23, 2012 nowat 1:30 p.m. Pacific Time.

Barry G. Caldwell, President and CEO, will review the company's recent financial results and current business developments. Deborah Andrews, CFO, will also be attending.  STAAR will offer a live video webcast of its presentation on the Company's website, [ www.staar.com ], under Investor Information. An archived replay of the presentation will be available for 30 days, also at [ www.staar.com ].

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye.  All of these lenses are foldable, which permits the surgeon to insert them through a small incision.  STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL."  A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL."  Over 300,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: [ www.visianinfo.com ].  STAAR has approximately 300 full time employees and markets lenses in over 60 countries.  Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA.  For more information, please visit the Company's website at [ www.staar.com ] or call 626-303-7902. 

Collamer® is the registered trademark for STAAR's proprietary biocompatible collagen copolymer lens material. 

CONTACT: 

Investors

Media


EVC Group

EVC Group


Douglas Sherk, 415-652-9100

Chris Gale


Jenifer Kirtland, 415-568-9349

646-201-5431

SOURCE STAAR Surgical Company

[ Back to top ]

RELATED LINKS
[ http://www.staar.com ]


Publication Contributing Sources